Janney Capital Management LLC trimmed its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 10.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,656 shares of the biopharmaceutical company’s stock after selling 5,774 shares during the […] Read this story